| Literature DB >> 21879269 |
Krzysztof Bujko1, Andrzej Rutkowski, George J Chang, Wojciech Michalski, Ewa Chmielik, Jerzy Kusnierz.
Abstract
BACKGROUND: Distal intramural spread is present within 1 cm from visible tumor in a substantial proportion of patients. Therefore, ≥ 1 cm of distal bowel clearance is recommended as minimally acceptable. However, clinical results are contradictory in answering the question of whether this rule is valid. The aim of this review was to evaluate whether in patients undergoing anterior resection, a distal bowel gross margin of <1 cm jeopardizes oncologic safety.Entities:
Mesh:
Year: 2011 PMID: 21879269 PMCID: PMC3278608 DOI: 10.1245/s10434-011-2035-2
Source DB: PubMed Journal: Ann Surg Oncol ISSN: 1068-9265 Impact factor: 5.344
Local recurrence rates in relation to the distal macroscopic bowel margin shorter versus longer than approximately 1 cm
| Study | % of patients with perioperative radiotherapya | % of excluded patients due to lack of margin measurement | Median distance from the anal verge to distal tumor edge (cm); short margin vs. long margin or for all patients | Method of measurement of distal bowel marginb | Median or mean follow-up (mo) | Cutoff point (cm) | % of patients in the short margin group | No. of patients with recurrence/no. total (%) | Survival |
| ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Short margin | Long margin | Short margin | Long margin | |||||||||
| McDermott | 0 | 18.4 | ND | Fixed specimen | ND | <1 | 2.6 | 3/13 (23.1) | 95/492 (19.3) | ND | ND | ND |
| Hojo | 0 | 0 | ND | ND | ND | <1 | 2.6 | 1/7 (14.3) | 29/266 (10.1) | ND | ND | ND |
| Karanjia | 0 | 0 | 4.7 | Pathologist fixed unnpined | ND | ≤1 | 27.6 | 0/42 (0) | 4/110 (3.6) | ND | ND | ND |
| Vernava | 0 | 1.6 | 8 vs. 10 | Pathologist, fresh tissue | 42 | ≤0.8 | 8.4 | 7/20 (35.0) | 42 /219 (19.2) | OS 49.3 | OS, 67.3 | 0.01 |
| Bokey | 0 | 0 | ND | Pathologist, fresh tissue | 67 | ≤1 | 6.5 | 9/39 (23.1) | 50/557 (9.0) | ND | ND | ND |
| Kuvshinoff | 100 | ND | Fixed specimen | 33 | ≤1 | 57.1 | 1/16 (6.3) | 0/12 (0) | DFS 53 | DFS, 85 | 0.06 | |
| Andreola | 61 | 0 | All between 4–5 | Pinned, fixed | 51 | <1 | 40.8 | 4/31 (12.9) | 3/45 (6.6) | RR 90.3 28/31 | RR, 82.4, 37/45 | 0.78 |
| Stocchi | 100 | ND | ND | ND | 80 | <1 | 15.3 | 7/54 (13.0) | 42/298 (14.1) | OS 64 | OS, 1–2 cm 58, > 2 cm 65 | 0.27 |
| Law | 4.4 | ND | 7.2 | ND | 35.5 | ≤1 | 22.5 | 6/60 (10.0) | 6/207 (2.9) | ND | ND | ND |
| Huh | 100 | 0 | All < 6, median 3.7 | ND | 56.2 | ≤1 | 41.9 | 3/18 (16.7) | 0/25 (0) | OS 72.2 | OS, 78.6 | 0.713 |
| Rutkowski | 100 | 8.8 | 6 vs. 7 | Pinned, fixed | 48 | ≤1 | 25.6 | 4/42 (9.5) | 17/122 (13.9) | 65.6 | 68.7 | 0.663 |
| Kim | 71.2 | 19.8 | ND | pathologist | 65 | ≤1 | 18.3 | 7/163 (4.3) | 28/744 (3.8) | ND | ND | ND |
| Rutkowski | 63.3 | 13.5 | 7.6 | Pathologist, fixed, unnpined | 75 | <1 | 23.4 | 4/96 (4.2) | 13/314 (4.1) | OS 77.9 | OS 77.0 | 0.957 |
| Pricolo | 100 | 0 | ND | Pathologist | 48 | <1 | 30.3 | 0/10 (0) | 0/23 (0) | ND | ND | ND |
| Kiran | 40 | ND | 6 vs. 8 | Pathologist, fresh tissue | 49 | ≤1 | 25.3 | 7/198 (3.5) | 19/586 (3.2) | DFS 67.4 | DFS, 66.5 | 0.77 |
| Silberfein | 88 | 32.4 | 2.0 | Pathologist, fresh tissue | 94 | ≤1 | 31.1 | 3/37 (8.1) | 6/82 (7.3) | ND | ND | ND |
| Nash | 72 | 0 | 45% within 6 cm | Pathologist, fixed, pinned | 70 | <0.8 | 16.3 | 13/102 (12.7) | 29/524 (5.5) | ND | ND | ND |
ND no data, OS overall survival at 5 years, DFS disease-free survival OS at 5 years (4 years in Kuvshinoff et al.15), RR row rate of survival, NS nonsignificant
aPreoperative radiotherapy Refs.7,8,15,19,20,22, postoperative radiotherapy Refs.16,17, preoperative radiation in most patients and postoperative radiation in some patients Refs.9,18, postoperative radiation in most patients and preoperative radiation in some Ref.21
bThe following information was gathered: who measured the margin (surgeon or pathologist); was measurement done on fresh tissue or on fixed tissue; and was the specimen pinned or unpinned. Lack of any of the this information indicates that the relevant data were not provided
cOnly anastomotic recurrences are described
dOnly N0 patients were studied
Fig. 1The differences with 95% confidence intervals in local recurrence rates between the groups with the distal bowel margin shorter than ~1 cm and the groups with longer distal margin
Anastomotic recurrence rates in relation to the distal bowel margin shorter versus longer than approximately 1 cm
| Study | No. of patients with anastomotic recurrence/total no. of patients (%) | |
|---|---|---|
| Distal bowel resection margin <1 cm | Distal bowel resection margin >1 cm | |
| Hojo | 1/7 (14.3) | 29/266 (10.1) |
| Vernava | 6/20 (30.0) | 23/219 (10.5) |
| Kuvshinoff | 0/16 (0) | 0/12 (0) |
| Kim | 7/163 (4.3) | 28/744 (3.8) |
| Rutkowski | 0/96 (0) | 4/314 (1.3) |
| Nash | 8/102 (7.8) | 8/524 (1.5) |
Local recurrence rates in relation to the distal margin ≤5 mm vs. >5 mm
| Study | No. of patients with local recurrence/total no. of patients (%) | Survival |
| ||
|---|---|---|---|---|---|
| Distal bowel resection margin ≤5 mm | Distal bowel resection margin >5 mm | Distal bowel resection margin ≤5 mm | Distal bowel resection margin >5 mm | ||
| Kuvshinoff | 1/9 (11.1) | 0/19 (0) | ND | ND | |
| Andreola | 1/18 (5.6) | 2/48 (4.2) | RR, 100% (0/21) | RR, 83.3% (8/48) | 0.099 |
| Rutkowski | 1/11 (9.1) | 20/152 (13.2) | OS, 62.5% | OS, 67.8% | 0.912 |
| Rutkowski | 3/58 (5.2) | 14/352 (4.0) | OS, 82.4% | OS, 76.3% | 0.581 |
| Kiran | 4/77 (5.1) | 22/706 (3.1) | DFS, 63% | DFS, 63% | 0.49 |
ND no data, OS overall survival at 5 years, DFS disease-free survival at 5 years, RR row rate of survival
Fig. 2The differences with 95% confidence intervals in local recurrence rates between the groups with the distal bowel margin shorter or equal to 0.5 cm and the groups with longer distal margin
Local recurrence rates in patients with ≤2 mm of gross bowel margin
| Study | Length of distal bowel margin | No. of patients with local recurrence/total no. of patients (%) | Survival |
|---|---|---|---|
| Rutkowski | Positive margin | 0/3 (0) | 100; follow-up 39–44 mo |
| Rutkowski | Positive margin | 0/18 (0) | 83.3; 5-y overall survival |
| Kiran | Margin ≤2 mm | 1/28 (3.6) | Disease-free survival similar to that seen in patients with >2-mm margin |
| Nash | Margin = 1 mm | 1/19 (5.3) | 84.2; row rate of cancer-specific survival; median follow-up of ~6.5 years |
| Andreola | Margin ≤2 mm | 0/5 (0) | 100; row rate survival; median follow-up of ~4 years |
| Total | 2/73 (2.7, 95% CI 0–6.4) | ||
Patients with microscopically positive bowel margin in case of hand-sewn anastomosis and patients with microscopically positive stapler doughnuts were excluded
aOf 13 patients with positive gross margin (stapler doughnuts clear), the following microscopic findings were recorded at the margin: cancer, 4; adenoma, 2; fibroinflammatory tissue but cancer in the other part of the specimen, 2; fibroinflammatory tissue, pathologic complete response, 1; no data, 4